FSRH Guideline (January 2019, amended October 2023) Combined Hormonal Contraception

doi:10.1136/bmjsrh-2018-chc

Cited by 9 publications

(3 citation statements)

References 356 publications

(208 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Long-acting reversible contraception (LARC) requires administration by a healthcare professional [17,22,23] – with the exception of the Sayana-Press (depot medroxyprogesterone acetate) subcutaneous injection [24]. Thus, due to the restrictions on face- to-face appointments, LARC administration severely decreased throughout the COVID-19 pandemic (Figure 3).…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

How COVID-19 continues to affect contraception in Scotland: a retrospective analysis of Scottish prescribing data between 2016 and 2023

Johnson-Hall

2023

Preprint

View full text Add to dashboard Cite

Background In Scotland, the effects of the COVID-19 pandemic on women's access to contraception are unknown. Globally, COVID-19 restrictions have led to a shift to telehealth service delivery alongside a reduction in contraceptive provision. Research into whether the effects of COVID-19 on contraception have abated after restrictions have been lifted is lacking. Methods This is a retrospective longitudinal study of prescribing data from the Scottish Health and Social Care Open Data repository (https://www.opendata.nhs.scot) between January 2016 and January 2023. Contraceptives were extracted and categorised using truncated British National Formulary codes and analysed using R. Contraceptive provision was compared across four periods: pre-COVID-19 (01/01/2016-23/03/2020), lockdown (24/03/2020-9/05/2020 & 05/01/2021-26/04/2021), restrictions (30/05/2020-04/01/2021 & 27/04/2021-30/04/2022), and post-COVID-19 (01/05/2022-01/01/2023). Results During lockdowns, contraceptive prescribing in Scotland decreased by 82.90% of pre-COVID-19 levels. This trend was more severe for long-acting reversible contraception which fell to 11.80% of pre-COVID-19 prescriptions. After COVID-19, the level of contraceptive prescribing has risen to 108.23% of its pre- pandemic level. Large increases in subcutaneous medroxyprogesterone acetate (499.05%), progestogen- only pills (125.07%), the patch (165.09%), levonorgestrel-IUS (112.54%), and ulipristal acetate emergency contraception prescribing (357.97%). Conversely, combined oral contraceptive pills (75.04%), Cu-IUD (83.63%), the implant (81.10%), and levonorgestrel emergency contraception (67.42%) prescribing has decreased. Conclusions COVID-19 vastly decreased contraceptive prescribing during lockdowns in Scotland. Post-COVID-19, changes in contraceptive prescribing within Scottish general practices are reported, with implications for health policy and service delivery planning.

show abstract

Section: Resultsmentioning

confidence: 99%

“…COVID-19 restrictions prevented the regular BMI and blood pressure monitoring required for safe COCP prescribing [17]. This likely led to the decrease seen in COCP prescribing and the growth in dispensing of POPs instead, which do not require the same patient monitoring [17–19].…”

Section: Discussionmentioning

confidence: 99%

How COVID-19 continues to affect contraception in Scotland: a retrospective analysis of Scottish prescribing data between 2016 and 2023

Johnson-Hall

2023

Preprint

View full text Add to dashboard Cite

show abstract

“…1 While changes are few, there are some important new recommendations relating to pill use patterns, reminders relating to safety and effectiveness, and new resources for clinicians.…”

mentioning

confidence: 99%

The new FSRH guideline on Combined Hormonal Contraception: how does it change practice?

Simpson

2019

BMJ Sex Reprod Health

View full text Add to dashboard Cite

Thrombophilieabklärung im Hinblick auf östrogenhaltige Kontrazeptiva und Hormonersatztherapie

Pollak

Nagler

2019

Gynäkologische Endokrinologie

View full text Add to dashboard Cite

FSRH Guideline (January 2019, amended October 2023) Combined Hormonal Contraception

Cited by 9 publications

References 356 publications

How COVID-19 continues to affect contraception in Scotland: a retrospective analysis of Scottish prescribing data between 2016 and 2023

How COVID-19 continues to affect contraception in Scotland: a retrospective analysis of Scottish prescribing data between 2016 and 2023

The new FSRH guideline on Combined Hormonal Contraception: how does it change practice?

Thrombophilieabklärung im Hinblick auf östrogenhaltige Kontrazeptiva und Hormonersatztherapie

Contact Info

Product

Resources

About